Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pravastatin for Prevention of Radiation-Induced Fibrosis in Breast Cancer
NCT04385433Phase 3Terminated
- Sponsor
- Institut du Cancer de Montpellier
- Start
- Dec 2020
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in radiation-induced fibrosis (RIF) comparing Pravastatin + RT with Placebo + RT (2 arms). Primary endpoint: Occurrence of grade >=2 breast fibrosis at 24 months. Started Dec 2020; status: terminated.
02
Drugs
pravastatin
03
Conditions
radiation-induced fibrosis (RIF)
Beyond the preview
Go deeper on NCT04385433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04385433.